Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 14 | $4,350,941 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
25 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 21 Mar 2024 | Sale | 14,491 | 35.31 | 511,677 | D |
22 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 20 Mar 2024 | Sale | 400 | 35.31 | 14,124 | D |
21 Mar 2024 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 19 Mar 2024 | Sale | 12,364 | 35.31 | 436,573 | D |
15 Mar 2024 18:39 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 13 Mar 2024 | Sale | 36,116 | 33.48 | 1,209,164 | D |
15 Mar 2024 18:39 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 13 Mar 2024 | Sale | 26,250 | 34.1 | 895,125 | D |
14 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 12 Mar 2024 | Sale | 3,884 | 32.99 | 128,133 | D |
28 Feb 2024 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 26 Feb 2024 | Sale | 5,000 | 30.21 | 151,050 | D |
12 Jan 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 10 Jan 2024 | Sale | 8,000 | 27.91 | 223,280 | D |
20 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | NEWHALL CHARLES W III | Director | 16 Nov 2023 | Sale | 2,500 | 28.01 | 70,025 | D |
17 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | HUDSON FREDERICK M. | Director | 15 Nov 2023 | Sale | 5,211 | 28.5 | 148,514 | D |
17 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | HUDSON FREDERICK M. | Director | 15 Nov 2023 | Sale | 3,882 | 28.5 | 110,637 | D |
16 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MOTTOLA FRANK | SVP, Quality, GMP, Ops, IT | 14 Nov 2023 | Sale | 1,110 | 28.13 | 31,224 | D |
01 Sep 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 30 Aug 2023 | Sale | 8,100 | 32 | 259,200 | D |
29 Aug 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 25 Aug 2023 | Sale | 5,135 | 31.59 | 162,215 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)